Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 15.51% is in line with its 5-year average of 16.61%, near the low end of its 5-year range (13.60%–20.25%).
As of the fiscal period ended Tuesday, June 30, 2026. 0.25% below its 12-month average of 15.55%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation.
RETURN ON EQUITY (ROE)
15.51%
RETURN ON EQUITY (ROE) AVG TTM
15.55%
RETURN ON EQUITY (ROE) AVG 3Y
15.35%
RETURN ON EQUITY (ROE) AVG 5Y
16.61%
RETURN ON EQUITY (ROE) AVG 10Y
15.49%
RETURN ON EQUITY (ROE) AVG 15Y
15.09%
RETURN ON EQUITY (ROE) AVG 20Y
15.64%
CURRENT VS TTM AVG
-0.25%
CURRENT VS 3Y AVG
+1.04%
CURRENT VS 5Y AVG
-6.63%
CURRENT VS 10Y AVG
+0.14%
CURRENT VS 15Y AVG
+2.81%
CURRENT VS 20Y AVG
-0.85%
SECTOR MEDIAN · HEALTHCARE
11.44%
median of 88 covered companies
CURRENT VS SECTOR MEDIAN
+35.58%
vs the sector median at left
The Ensign Group, Inc.
Market Cap
$10.11B
Return on Equity (ROE)
15.51%
TTM Avg
15.55%
3Y Avg
15.35%
5Y Avg
16.61%
Market Cap
$10.28B
Return on Equity (ROE)
12.77%
TTM Avg
11.88%
3Y Avg
12.69%
5Y Avg
13.50%
Market Cap
$9.93B
Return on Equity (ROE)
26.39%
TTM Avg
25.41%
3Y Avg
19.99%
5Y Avg
14.02%
Market Cap
$10.37B
Return on Equity (ROE)
-0.17%
TTM Avg
18.91%
3Y Avg
22.60%
5Y Avg
24.60%
Market Cap
$10.45B
Return on Equity (ROE)
20.31%
TTM Avg
18.80%
3Y Avg
15.17%
5Y Avg
15.31%
Market Cap
$10.50B
Return on Equity (ROE)
3.10%
TTM Avg
-8.94%
3Y Avg
-15.72%
5Y Avg
1.14%
Market Cap
$11.13B
Return on Equity (ROE)
11.23%
TTM Avg
7.12%
3Y Avg
6.90%
5Y Avg
7.16%
Market Cap
$11.35B
Return on Equity (ROE)
8.63%
TTM Avg
6.23%
3Y Avg
8.78%
5Y Avg
10.01%
Market Cap
$11.38B
Return on Equity (ROE)
9.77%
TTM Avg
10.54%
3Y Avg
10.84%
5Y Avg
19.93%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| The Ensign Group, Inc. (ENSG) | $10.11B | 15.51% | 15.55% | 15.35% | 16.61% |
| Henry Schein, Inc. (HSIC)vs › | $10.28B | 12.77% | 11.88% | 12.69% | 13.50% |
| Insulet Corp. (PODD)vs › | $9.93B | 26.39% | 25.41% | 19.99% | 14.02% |
| Molina Healthcare, Inc. (MOH)vs › | $10.37B | -0.17% | 18.91% | 22.60% | 24.60% |
| Universal Health Services, Inc. (UHS)vs › | $10.45B | 20.31% | 18.80% | 15.17% | 15.31% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $10.50B | 3.10% | -8.94% | -15.72% | 1.14% |
| Globus Medical, Inc. (GMED)vs › | $11.13B | 11.23% | 7.12% | 6.90% | 7.16% |
| Bio-Techne Corporation (TECH)vs › | $11.35B | 8.63% | 6.23% | 8.78% | 10.01% |
| Align Technology, Inc. (ALGN)vs › | $11.38B | 9.77% | 10.54% | 10.84% | 19.93% |
| DaVita Inc. (DVA)vs › | $11.48B | -114.70% | 329.18% | 200.63% | 164.66% |
ROE
15.5%
ROA
6.6%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | 15.51% |
| 2026-03-31 | 15.36% |
| 2025-12-31 | 15.39% |
| 2025-09-30 | 15.49% |
| 2025-06-30 | 16.00% |
| 2025-03-31 | 16.06% |
| 2024-12-31 | 16.22% |
| 2024-09-30 | 13.73% |
| 2024-06-30 | 13.60% |
| 2024-03-31 | 13.84% |
| 2023-12-31 | 14.04% |
| 2023-09-30 | 17.00% |
| 2023-06-30 | 17.33% |
| 2023-03-31 | 17.77% |
| 2022-12-31 | 18.01% |
| 2022-09-30 | 18.05% |
| 2022-06-30 | 18.22% |
| 2022-03-31 | 18.27% |
| 2021-12-31 | 19.07% |
| 2021-09-30 | 19.63% |
| 2021-06-30 | 20.25% |
| 2021-03-31 | 20.41% |
| 2020-12-31 | 20.84% |
| 2020-09-30 | 19.82% |
| 2020-06-30 | 18.95% |
| 2020-03-31 | 18.37% |
| 2019-12-31 | 16.90% |
| 2019-09-30 | 15.96% |
| 2019-06-30 | 15.59% |
| 2019-03-31 | 15.27% |
| 2018-12-31 | 15.63% |
| 2018-09-30 | 13.74% |
| 2018-06-30 | 13.07% |
| 2018-03-31 | 11.73% |
| 2017-12-31 | 8.22% |
| 2017-09-30 | 9.92% |
| 2017-06-30 | 9.59% |
| 2017-03-31 | 9.62% |
| 2016-12-31 | 10.95% |
| 2016-09-30 | 10.36% |
| 2016-06-30 | 11.23% |
| 2016-03-31 | 12.04% |
| 2015-12-31 | 12.97% |
| 2015-09-30 | 12.93% |
| 2015-06-30 | 12.26% |
| 2015-03-31 | 9.82% |
| 2014-12-31 | 13.89% |
| 2014-09-30 | 15.45% |
| 2014-06-30 | 16.74% |
| 2014-03-31 | 13.39% |
| 2013-12-31 | 6.75% |
| 2013-09-30 | 3.71% |
| 2013-06-30 | 4.69% |
| 2013-03-31 | 4.92% |
| 2012-12-31 | 12.43% |
| 2012-09-30 | 15.34% |
| 2012-06-30 | 15.51% |
| 2012-03-31 | 16.35% |
| 2011-12-31 | 17.18% |
| 2011-09-30 | 18.40% |
| 2011-06-30 | 18.55% |
| 2011-03-31 | 18.15% |
| 2010-12-31 | 17.76% |
| 2010-09-30 | 17.35% |
| 2010-06-30 | 17.11% |
| 2010-03-31 | 17.19% |
| 2009-12-31 | 17.32% |
| 2009-09-30 | 17.66% |
| 2009-06-30 | 17.94% |
| 2009-03-31 | 17.78% |
| 2008-12-31 | 17.63% |
| 2008-09-30 | 17.41% |
| 2008-06-30 | 16.58% |
| 2008-03-31 | 16.71% |
| 2007-12-31 | 15.83% |
| 2007-09-30 | 30.94% |
| 2007-06-30 | 35.23% |
| 2007-03-31 | 38.53% |
| 2006-12-31 | 44.08% |
| 2005-12-31 | 56.35% |
